MEDIZINISCHE UNIVERSITAET WIEN - Austria 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
2019
Criterium:Position:
Overall Score:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:100-200
2018
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:200-300
Total Number of Projects:200-300
Networking Rank (Reputation):200-300
2017
Criterium:Position:
Overall Score:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:100-200
Networking Rank (Reputation):100-200
2016
Criterium:Position:
Overall Score:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:100-200
Networking Rank (Reputation):100-200
2015
Criterium:Position:
Overall Score:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:100-200
Networking Rank (Reputation):200-300
Partner Constancy:300-400
Project Leadership Index:100-200
2014
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:200-300
Total Number of Projects:100-200
Networking Rank (Reputation):400-500
Partner Constancy:200-300
Project Leadership Index:200-300
Diversity Index:300-400
2013
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:200-300
Total Number of Projects:58
Total Project Funding:200-300
Partner Constancy:51
Project Leadership Index:51
Diversity Index:44
2012
Criterium:Position:
Overall Score:100-200
Total Project Funding per Partner:200-300
Total Number of Projects:55
Total Project Funding:100-200
Networking Rank (Reputation):100-200
Networking Rank (Reputation):100-200
Partner Constancy:42
Project Leadership Index:32
Diversity Index:22
2011
Criterium:Position:
Overall Score:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:100-200
Total Project Funding:200-300
Networking Rank (Reputation):200-300
Partner Constancy:500-600
Project Leadership Index:71
Diversity Index:200-300
2010
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:100-200
Total Number of Projects:100-200
Total Project Funding:100-200
Networking Rank (Reputation):100-200
Partner Constancy:300-400
Project Leadership Index:200-300
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:100-200
Total Project Funding:200-300
Networking Rank (Reputation):200-300
Partner Constancy:> 1000
Project Leadership Index:100-200
Diversity Index:300-400
2008
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:100-200
Total Number of Projects:100-200
Total Project Funding:100-200
Networking Rank (Reputation):200-300
Partner Constancy:200-300
Project Leadership Index:100-200
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Total Project Funding:400-500
Networking Rank (Reputation):300-400
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2022-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 198
As coordinator: 27
As participant: 147
Sole participant: 24
Coordinator / Participant Ratio: 0.18*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 4.348.126 236.740.109 5.028.643 4 5
2021 15.376.485 112.195.852 7.809.232 4 11
2020 30.104.588 38.275.936 12.463.193 5 8
2019 372.334 117.191.609 12.778.735 2 22
2018 8.354.934 49.055.297 8.713.014 7 8
2017 0 100.178.896 5.711.940 16
2016 11.515.435 83.257.841 12.609.056 4 14
2015 7.903.321 66.119.533 7.937.566 4 10
2014 708.985 20.519.545 3.318.007 3 5
2013 3.958.540 62.418.500 6.196.103 3 13
2012 19.099.344 43.972.824 6.002.703 6 10
2011 9.620.449 38.272.842 8.165.404 7 11
2010 6.078.273 84.660.492 7.239.355 2 14

Networking:

Partners:

Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE32
CHARITE UNIVERSITAETSMEDIZIN BERLIN18
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM18
KATHOLIEKE UNIVERSITEIT LEUVEN17
UNIVERSITY COLLEGE LONDON16
DANMARKS TEKNISKE UNIVERSITET15
UNIVERSITAIR MEDISCH CENTRUM UTRECHT15
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE14
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V14
KAROLINSKA INSTITUTE14
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM13
KING'S COLLEGE LONDON13
REGION HOVEDSTADEN13
ACADEMISCH ZIEKENHUIS GRONINGEN11
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD11
UNIVERSITEIT GENT11
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN10
UPPSALA UNIVERSITET10
MASARYKOVA UNIVERZITA9
UNIVERSITY OF HELSINKI9
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT8
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE8
JANSSEN PHARMACEUTICA NV8
MEDIZINISCHE UNIVERSITAT GRAZ8
MEDIZINISCHE UNIVERSITAT INNSBRUCK8
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE8
THE UNIVERSITY OF LIVERPOOL8
UNIVERSITA DEGLI STUDI DI TORINO8
UNIVERSITY OF COPENHAGEN8
UNIVERSITY OF GLASGOW8
UNIVERSITY OF NEWCASTLE UPON TYNE8
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS7
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS7
CONSIGLIO NAZIONALE DELLE RICERCHE7
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK7
INSTITUT CURIE7
NOVARTIS PHARMA7
PFIZER LIMITED7
SERVICIO MADRILENO DE SALUD7
THE UNIVERSITY OF MANCHESTER7
UNIVERSITAET ZUERICH7
UNIVERSITAETSKLINIKUM AACHEN7
UNIVERSITAT WIEN7
UNIVERSITEIT UTRECHT7
UNIVERSITY OF TURKU7
WAGENINGEN UNIVERSITY7
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH6
INSERM TRANSFERT6
INSTITUT PASTEUR6
KLINIKUM DER UNIVERSITAET ZU KOELN6
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN6
MEDIZINISCHE HOCHSCHULE HANNOVER6
NEDERLANDSE ORGANISATIE VOOR TOEGEPAST NATUURWETENSCHAPPELIJK ONDERZOEK TNO6
STICHTING VU6
TECHNISCHE UNIVERSITAET WIEN6
UNIVERSITAET BERN6
UNIVERSITAETSKLINIKUM FREIBURG6
UNIVERSITEIT ANTWERPEN6
UNIVERSITEIT MAASTRICHT6
UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK6
UNIVERSITY OF BRISTOL6
UNIVERSITY OF LEEDS6
UNIVERSITY OF WALES CARDIFF6
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS5
ALBERT LUDWIGS UNIVERSITAET FREIBURG5
CARL ZEISS5
COMMISSARIAT A L'ENERGIE ATOMIQUE5
EUROPEAN MOLECULAR BIOLOGY LABORATORY5
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE5
HEINRICHHEINEUNIVERSITAET DUESSELDORF5
INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONNEMENT5
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI5
ISTITUTO SUPERIORE DI SANITA5
KLINIKUM DER UNIVERSITAET REGENSBURG5
LEIDEN UNIVERSITY5
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV5
MILTENYI BIOTEC5
OSLO UNIVERSITETSSYKEHUS HF5
PHILIPPS UNIVERSITAET MARBURG5
PHILIPS ELECTRONICS NEDERLAND BV5
STICHTING VUMC5
TARTU ULIKOOL5
TECHNISCHE UNIVERSITAET DRESDEN5
TECHNISCHE UNIVERSITAET MUENCHEN5
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE5
UNIVERSIDAD POLITECNICA DE MADRID5
UNIVERSIDADE NOVA DE LISBOA5
UNIVERSITA DEGLI STUDI DI FIRENZE5
UNIVERSITAETSKLINIKUM HEIDELBERG5
UNIVERSITAETSMEDIZIN GOETTINGEN GEORGAUGUSTUNIVERSITAET GOETTINGEN STIFTUNG OEFFENTLICHEN RECHTS5
UNIVERSITY OF BIRMINGHAM5
UNIVERSITY OF BOLOGNA5
UNIVERSITY OF EAST ANGLIA5
UNIVERZA V LJUBLJANI5
WEIZMANN INSTITUTE OF SCIENCE5
ASTRAZENECA4
AUSTRIAN RESEARCH CENTERS SIEBERDORF4
BAYER4
BAYER PHARMA4
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG4

Constancy:

Total number of partners: 2635
Partner loyalty:
Frequent Partner: (> 2 projects): 1156
Rare Partner: 1479
Frequent / Rare Partner Ratio: 0.78

Project overview:

Start dateProjectacronymrolefundingpartners
2022-09-01Allergenicity Prediction Toolbox for novel foods ALLPreTparticipant2.642.60224
2022-09-01Climate Monitoring and Decision Support Framework for Sand Fly-borne Diseases Detection and Mitigation with COst-benefit and Climate-policy MeasureS CLIMOSparticipant9.038.53029
2022-09-01STOP SPREAD BAD BUGS: novel antimicrobial approaches to combat multidrug resistance in bacteria STOP SPREAD BAD BUGSparticipant4.060.35423
2022-09-01Transient inactivation of hypothalamic hormone release to prevent post-traumatic stress sensitization SECRET-DOCKcoordinator150.0001
2022-07-01Immunomodulatory properties of L. plantarum extracellular vesicles in airway allergy LactoVEScoordinator199.4412
2022-05-01Neuropeptidergic modulation of synaptic circuits in fear and anxiety PeptidesAndFearcoordinator1.499.7251
2022-05-01Partnership for the Assessment of Risks from Chemicals PARCparticipant200.000.000199
2022-02-01Integrated Services for Infectious Disease Outbreak Research ISIDOReparticipant20.998.624154
2022-01-01Life-long cross-generational priming of the hypothalamus for obesity FOODFORLIFEcoordinator2.498.9601
2021-06-01Cancer prevention and early detection among the homeless population in Europe: Co-adapting and implementing the Health Navigator Model CANCERLESScoordinator2.820.32612
2021-06-01Role of stress-induced modulation of B cell function in cardiovascular disease SBCVDcoordinator270.3492
2021-05-01PERSONALISATION OF IMMUNOSUPPRESSION BY MONITORING VIRAL LOAD POST KIDNEY TRANSPLANTATION - A RANDOMISED CONTROLLED PHASE II TRIAL TTV GUIDE TXcoordinator6.099.83121
2021-04-01AN INNOVATIVE ANALYTICAL PLATFORM TO INVESTIGATE THE EFFECT AND TOXICITY OF MICRO AND NANO PLASTICS COMBINED WITH ENVIRONMENTAL CONTAMINANTS ON THE RISK OF ALLERGIC DISEASE IN PRECLINICAL AND CLINICAL Imptoxparticipant6.104.82312
2021-03-01Real-time Adaptive Particle Therapy of Cancer RAPTORparticipant3.967.11113
2021-03-01European Network Linking Informatics and Genomics of Helper T cells in Tissues ENLIGHT-TENplusparticipant4.067.52615
2021-03-01Evolutionary games and population dynamics: from theory to applications EvoGamesPlusparticipant3.980.39014
2021-02-01Central Repository for Digital Pathology BIGPICTUREparticipant32.319.82551
2021-01-28VACCELERATE - European Corona Vaccine Trial Accelerator Platform VACCELERATEparticipant26.499.80432
2021-01-01Cyber-Physical Intensive Care Medical System for Covid-19 ICU4Covidparticipant10.497.10226
2021-01-01Revealing drug tolerant persister cells in cancer using contrast enhanced optical coherence and photoacoustic tomography REAPcoordinator6.185.9799
2021-01-01Perspectives For Future Innovation in Tendon Repair P4 FITparticipant4.043.0406
2021-01-01INK-BASED HYBRID MULTI-MATERIAL FABRICATION OF NEXT GENERATION IMPLANTS INKplantparticipant5.988.15519
2021-01-01Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy T2EVOLVEparticipant8.728.18529
2021-01-01LETHE (λήθη) – A personalized prediction and intervention model for early detection and reduction of risk factors causing dementia, based on AI and distributed Machine Learning LETHEparticipant5.999.88915
2020-12-01Link Skin Morphology and Vasculature with Diseases using Optical Imaging SkinOptimacoordinator270.3493
2020-12-01ROles of ePitranscriptomic in diseasES ROPESparticipant3.095.82911
2020-10-01H2O Health Outcomes Observatory H2Ocoordinator10.476.68725
2020-10-01Using cell-cell interactions to unlock new cancer treatments: Forcing neural crest tumors back onto the developmental path KILL-OR-DIFFERENTIATcoordinator9.377.1516
2020-10-01Switchable magneto-plasmonic contrast agents and molecular imaging technologies SWIMMOTparticipant3.466.5696
2020-09-01Photonics for Healthcare: multiscAle cancer diagnosiS and Therapy PHASTparticipant3.939.91814
2020-04-01Three Rapid Diagnostic tests (Point-of-Care) for COVID-19 CoronaThree Rapid Diagnostic tests (Point-of-Care) for Coronavirus, improving epidemic preparedness, public health and socio-economic benefits CORONADXparticipant2.970.2099
2020-03-01Dna Damage REsponse: Actionabilities, Maps and Mechanisms DDREAMMparticipant8.865.9654
2020-03-01Training towards Personalized Antibiotic Treatment TIPATparticipant3.969.5837
2020-02-01NEUROtransmitter TRANSporters: from single molecules to human pathologies NeuroTranscoordinator3.994.42212
2020-01-01Point-of-care instrument for diagnosis and image-guided intervention of Colo-Rectal Cancer PROSCOPEparticipant5.999.38411
2020-01-01Drug combinations for rewriting trajectories of renal pathologies in type II diabetes (DC-ren) DC-renparticipant5.968.4808
2020-01-01Handheld optical coherence tomography HandheldOCTcoordinator5.985.9799
2019-11-01Training European Experts in Multiscale Studies of Neural Crest Development and Disorders: from Patient to Model Systems and Back again. NEUcrestparticipant4.156.40511
2019-11-01EU Patient- cEntric clinicAl tRial pLatform EU-PEARLparticipant12.004.95337
2019-11-01Innovative strategies for cancer prevention with focus on sex hormone signaling and chronic inflammation CANCERPREVparticipant4.096.0147
2019-10-01Exploitation of the SECRETory pathway for cancer therapy to address European research SECRETparticipant3.915.87212
2019-10-01SUStainable INsect CHAIN SUSINCHAINparticipant7.952.54735
2019-07-01Glutamate dynamics during visual stimulation and ketamine challenge in the human brain GLU-IMAGEcoordinator186.1671
2019-07-01Antibiotic Distribution and Recovery in Tissue AB-DiRecTparticipant3.429.2176
2019-07-01NOVEL GRAM-NEGATIVE ANTIBIOTIC NOW GNA NOWparticipant12.299.99511
2019-07-01Periconceptional Programming of Health Training Network DohART-NETparticipant3.480.36919
2019-06-01Natural Integration of Bionic Limbs via Spinal Interfacing Natural BionicSparticipant9.984.0213
2019-05-01Repair of DNA lesions induced by platinum drugs REAPcoordinator186.1672
2019-05-01Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs RespiriNTMparticipant5.687.9849
2019-05-01Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors RespiriTBparticipant6.840.0009

overview shows latest 50 from 198 projects (2010-01-01 - 2022-12-31)
A full list of projects can be found here: